8Stock.Com Real Time Signal Analysis By Industry Sectors

8Stock.Com Real Time Signal Analysis
By Industry Sectors.

RSS Stock Market Analysis With Sector Related News Feed

Free Bursa Malaysia (KLSE) Hot Share Tips, Blogs / Forums, Research & Resources

Bursa Malaysia Free Hot Share Tips, Blogs / Forums, Research & KLSE Resources

INDUSTRY SECTOR Real Time Intraday Signal

US (Nasdaq, NYSE, AMEX) RSS News Feed

Live Link | INSURANCE | RSS News Feed | LTrader

HEALTH CARE, BIOTECHNOLOGY, DRUGS, PHARMACEUTICALS, MEDICAL

Live Link | HEALTH CARE | RSS News Feed | LTrader

BioSante rallies on study; drug stocks slip - MarketWatch

BioSante rallies on study; drug stocks slip
MarketWatch
The NYSE Arca Pharmaceutical Index (INDEX:DRG) was up nominally at 306.63 while the NYSE Arca Biotechnology Index (INDEX:BTK) eased slightly to rest at ...
BioSante soars on study; drug stocks slipMarketWatch

all 42 news articles »

XOMA Reports 2009 and Fourth Quarter Financial Results - CNNMoney.com (press release)

XOMA Reports 2009 and Fourth Quarter Financial Results
CNNMoney.com (press release)
As a result, more than 50 pharmaceutical and biotechnology companies have signed BCE licenses, and several licensed product candidates are in clinical ...

and more »

Abbott agrees to acquire Facet Biotech for USD450m - Trading Markets (press release)

BNET

Abbott agrees to acquire Facet Biotech for USD450m
Trading Markets (press release)
Pharmaceuticals and medical products supplier Abbott Laboratories (NYSE: ABT | Quote | Chart | News | PowerRating) said on Tuesday that has signed a ...
Facet, InterMune lead drug stocks northMarketWatch
Abbott's New AdditionInvestopedia
Facet Biotech Wooed by $722M Acquisition Offer from AbbottBioWorld Online
FOXBusiness -StreetInsider.com (subscription) (blog) -Reuters
all 490 news articles »

Nymox Reports 2009 Financial Results - CNNMoney.com (press release)

Nymox Reports 2009 Financial Results
CNNMoney.com (press release)
Nymox Pharmaceutical Corporation is a biotechnology company engaged in the research and development of therapeutics and diagnostics, with a particular ...

and more »

Investing in the Biotechnology Industry - Wealth Daily

Investing in the Biotechnology Industry
Wealth Daily
Last week, Astellas Pharma announced a hostile $3.5 billion offer for OSI Pharmaceuticals ( NASDAQ: OSIP) or $52 a share — a 40% premium over the previous ...

Follow the 'Strong Hands' Into Ironwood Pharmaceuticals (IRWD) - StreetInsider.com (subscription)

Follow the 'Strong Hands' Into Ironwood Pharmaceuticals (IRWD)
StreetInsider.com (subscription)
A number of investment funds have piled into recent biotech IPO Ironwood Pharmaceuticals (Nasdaq: IRWD), as disclosed in 13G filings and other filings over ...

Abraxis BioScience Reports 2009 Fourth Quarter and Full Year Financial Results - MarketWatch (press release)

Abraxis BioScience Reports 2009 Fourth Quarter and Full Year Financial Results
MarketWatch (press release)
LOS ANGELES, Mar 11, 2010 (BUSINESS WIRE) -- Abraxis BioScience, Inc. (NASDAQ:ABII) , a fully integrated biotechnology company, today reported financial ...

and more »

Biotech ETF Surges Again: The FBT and InterMune (ITMN) - ONN.tv

ETF Trends (blog)

Biotech ETF Surges Again: The FBT and InterMune (ITMN)
ONN.tv
... Biotechnology ETF (NYSE: FBT) is up more than 18% for the month of March due to explosive moves in two of its components, OSI Pharmaceuticals (NASDAQ: ...
Three Trends That Are Working for ETFsTheStreet.com (subscription)
ETF Spotlight: First Trust NYSE Arca Biotechnology (FBT)ETF Trends (blog)
Wednesday's ETF Movers: FBT, GDXMarketNewsVideo.com
Before It's News -Investor's Business Daily
all 11 news articles »

Collaboration revenue gives Synta $79.1M profit - Mass High Tech

Collaboration revenue gives Synta $79.1M profit
Mass High Tech
By Mass High Tech staff Despite reporting a fourth quarter loss, Lexington-based biotech Synta Pharmaceuticals Corp. ended 2009 with a net profit of $79.1 ...

and more »

Lexicon, Poniard lead decliners - MarketWatch

Lexicon, Poniard lead decliners
MarketWatch
Also lower, shares of Poniard Pharmaceuticals (NASDAQ:PARD) sank 9% to $1.61. AIG sold a unit to MetLife for $15 billion, but it will still be hard to raise ...
Lexicon Pharma says it will sell $95M in stockBusinessWeek
Lexicon, Poniard lead declinersMiddle East North Africa Financial Network

all 49 news articles »

Google News

TECHNOLOGY

World Wide Leader in Football match reviews, critics, reactions, rants

Copyright 2000,2001,2002,2003,2004 8Stock.Com All rights reserved.
Copying and or electronic transmission of this document
without the written consent of 8Stock.Com is a violation of the copyright law.